መነሻSDZNY • OTCMKTS
add
Sandoz Group ADR
የቀዳሚ መዝጊያ
$45.31
የቀን ክልል
$44.81 - $46.21
የዓመት ክልል
$27.79 - $46.80
የገበያው አጠቃላይ ዋጋ
18.01 ቢ CHF
አማካይ መጠን
69.36 ሺ
ፋይናንስ
የገቢ መግለጫ
ገቢ
የተጣራ ገቢ
(USD) | ጁን 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ገቢ | 2.53 ቢ | 2.68% |
የሥራ ወጪ | 1.02 ቢ | 7.11% |
የተጣራ ገቢ | 75.00 ሚ | -36.17% |
የተጣራ የትርፍ ክልል | 2.96 | -37.95% |
ገቢ በሼር | — | — |
EBITDA | 270.50 ሚ | -21.93% |
ውጤታማ የግብር ተመን | 25.98% | — |
ቀሪ ሒሳብ ሉሆች
አጠቃላይ ንብረቶች
አጠቃላይ ተጠያቂነቶች
(USD) | ጁን 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ | 701.00 ሚ | 451.97% |
አጠቃላይ ንብረቶች | 19.32 ቢ | 4.77% |
አጠቃላይ ተጠያቂነቶች | 10.95 ቢ | 9.80% |
አጠቃላይ እሴት | 8.37 ቢ | — |
የሼሮቹ ብዛት | 430.20 ሚ | — |
የገበያ ዋጋ እና የተገለጸ ዋጋ | 2.33 | — |
የእሴቶች ተመላሽ | 2.15% | — |
የካፒታል ተመላሽ | 3.24% | — |
የገንዘብ ፍሰት
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
(USD) | ጁን 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
የተጣራ ገቢ | 75.00 ሚ | -36.17% |
ከክወናዎች የተገኘ ጥሬ ገንዘብ | 114.50 ሚ | 169.41% |
ገንዘብ ከኢንቨስትመንት | -197.00 ሚ | -110.70% |
ገንዘብ ከፋይናንስ | -114.00 ሚ | -240.74% |
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ | -204.00 ሚ | -869.81% |
ነፃ የገንዘብ ፍሰት | 102.88 ሚ | -35.27% |
ስለ
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland. Sandoz is one of the leading global generics businesses. Wikipedia
ዋና ሥራ አስፈጻሚ
የተመሰረተው
1886
ድህረገፅ
ሠራተኞች
22,633